The University of Chicago Phase II Consortium (UC P2C) is a collaborative academic/community partnership funded by the National Cancer Institute to conduct early phase oncology clinical trials.
UC P2C Institutional Members and their Websites
- University of Chicago Comprehensive Cancer Center (UC P2C Chair: Walter M. Stadler, MD)
- Decatur Memorial Hospital, Decatur, IL (Site PI: James L. Wade III, MD)
- Fort Wayne Medical Oncology and Hematology, Indiana (Site PI: Sreenivasa Nattam, MD)
- Illinois CancerCare, Peoria, IL (Site PI: Sachdev P. Thomas, MD)
- Indiana University, Indianapolis, IN (Site PI: Noah M. Hahn, MD)
- Ingalls Memorial Hospital, Harvey, IL (Site PI: Mark Kozloff, MD)
- Mercy Hospital, St. Louis, MO (Site PI: Bethany Sleckman, MD)
- NorthShore University HealthSystem, Evanston, IL (Site PI: Bruce E. Brockstein, MD)
- Northwestern University, Chicago, IL (Site PI: Timothy M. Kuzel, MD)
- University of Maryland, Baltimore, MD (Site PI: Martin J. Edelman, MD)
- University of Michigan, Chicago, IL (Site PI: Maha Hussain, MD)
Scientific Leadership
Link to List of UC P2C Disease Oriented Groups and Leaders
UC P2C Primary Contacts
Link to UC Phase II Consortium (UC P2C) Primary Contact List
